Annual Accounts Receivable
$9.81 M
+$9.81 M+100.00%
December 31, 2021
Summary
- As of February 10, 2025, AVEO annual accounts receivable is $9.81 million, with the most recent change of +$9.81 million (+100.00%) on December 31, 2021.
- During the last 3 years, AVEO annual accounts receivable has risen by +$6.79 million (+224.22%).
Performance
AVEO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$18.72 M
+$3.44 M+22.50%
September 30, 2022
Summary
- As of February 10, 2025, AVEO quarterly accounts receivable is $18.72 million, with the most recent change of +$3.44 million (+22.50%) on September 30, 2022.
- Over the past year, AVEO quarterly accounts receivable has increased by +$10.41 million (+125.42%).
Performance
AVEO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AVEO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +125.4% |
| 3 y3 years | +224.2% | +1617.2% |
| 5 y5 years | +2340.6% | +688.1% |
AVEO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -47.6% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | -52.5% | -100.0% | -34.9% | -100.0% |
AVEO Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $18.72 M(+22.5%) |
| Jun 2022 | - | $15.28 M(+18.0%) |
| Mar 2022 | - | $12.94 M(+31.9%) |
| Dec 2021 | $9.81 M(>+9900.0%) | $9.81 M(+18.2%) |
| Sep 2021 | - | $8.30 M(+96.8%) |
| Jun 2021 | - | $4.22 M(+268.9%) |
| Mar 2021 | - | $1.14 M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2020 | - | $1.05 M(-12.9%) |
| Jun 2020 | - | $1.21 M(-56.5%) |
| Mar 2020 | - | $2.78 M(+70.4%) |
| Dec 2019 | $1.63 M(-46.1%) | $1.63 M(+49.6%) |
| Sep 2019 | - | $1.09 M(+78.4%) |
| Jun 2019 | - | $611.00 K(-76.2%) |
| Mar 2019 | - | $2.57 M(-15.0%) |
| Dec 2018 | $3.03 M(+652.7%) | $3.03 M(+779.7%) |
| Sep 2018 | - | $344.00 K(-64.6%) |
| Jun 2018 | - | $973.00 K(+62.2%) |
| Mar 2018 | - | $600.00 K(+49.3%) |
| Dec 2017 | $402.00 K(-60.9%) | $402.00 K(-83.1%) |
| Sep 2017 | - | $2.38 M(+433.7%) |
| Jun 2017 | - | $445.00 K(-34.2%) |
| Mar 2017 | - | $676.00 K(-34.2%) |
| Dec 2016 | $1.03 M(-77.9%) | $1.03 M(+3.7%) |
| Sep 2016 | - | $990.00 K(-24.0%) |
| Jun 2016 | - | $1.30 M(-25.0%) |
| Mar 2016 | - | $1.74 M(-62.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $4.64 M(+98.2%) | $4.64 M(+98.8%) |
| Sep 2015 | - | $2.33 M(+0.6%) |
| Jun 2015 | - | $2.32 M(+145.0%) |
| Mar 2015 | - | $947.00 K(-59.5%) |
| Dec 2014 | $2.34 M(+137.9%) | $2.34 M(+41.2%) |
| Sep 2014 | - | $1.66 M(+34.3%) |
| Jun 2014 | - | $1.24 M(-1.5%) |
| Mar 2014 | - | $1.25 M(+27.4%) |
| Dec 2013 | $984.00 K(-95.2%) | $984.00 K(-88.9%) |
| Sep 2013 | - | $8.89 M(+12.6%) |
| Jun 2013 | - | $7.90 M(-14.0%) |
| Mar 2013 | - | $9.18 M(-55.5%) |
| Dec 2012 | $20.65 M(+186.4%) | $20.65 M(+122.1%) |
| Sep 2012 | - | $9.30 M(+1.3%) |
| Jun 2012 | - | $9.18 M(-3.2%) |
| Mar 2012 | - | $9.49 M(+31.6%) |
| Dec 2011 | $7.21 M(+1744.0%) | $7.21 M(-26.0%) |
| Sep 2011 | - | $9.75 M(-66.1%) |
| Jun 2011 | - | $28.77 M(+257.5%) |
| Mar 2011 | - | $8.05 M(+1958.1%) |
| Dec 2010 | $391.00 K(-19.7%) | $391.00 K(+77.7%) |
| Sep 2010 | - | $220.00 K(+6.3%) |
| Jun 2010 | - | $207.00 K(-96.0%) |
| Mar 2010 | - | $5.15 M(+957.3%) |
| Dec 2009 | $487.00 K(-76.6%) | $487.00 K(-9.9%) |
| Sep 2009 | - | $540.70 K(-74.0%) |
| Dec 2008 | $2.08 M(+235.0%) | $2.08 M |
| Dec 2007 | $621.10 K | - |
FAQ
- What is AVEO Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals annual accounts receivable year-on-year change?
- What is AVEO Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals quarterly accounts receivable year-on-year change?
What is AVEO Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of AVEO is $9.81 M
What is the all time high annual accounts receivable for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high annual accounts receivable is $20.65 M
What is AVEO Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, AVEO annual accounts receivable has changed by +$9.81 M (+100.00%)
What is AVEO Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of AVEO is $18.72 M
What is the all time high quarterly accounts receivable for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high quarterly accounts receivable is $28.77 M
What is AVEO Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, AVEO quarterly accounts receivable has changed by +$10.41 M (+125.42%)